首页> 美国卫生研究院文献>Drug Metabolism and Disposition >Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes
【2h】

Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes

机译:包含衔接子蛋白的类似介素介素结构域的区域在介导的类似Toll受体3和4介导的肝药物代谢酶和转运蛋白的调控中包含介导干扰素β的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The expressions and activities of hepatic drug-metabolizing enzymes and transporters (DMETs) are altered during infection and inflammation. Inflammatory responses in the liver are mediated primarily by Toll-like receptor (TLR)-signaling, which involves recruitment of Toll/interleukin (IL)-1 receptor (TIR) domain containing adaptor protein (TIRAP) and TIR domain containing adaptor inducing interferon (IFN)-β (TRIF) that eventually leads to induction of proinflammatory cytokines and mitogen-activated protein kinases (MAPKs). Lipopolysaccharide (LPS) activates the Gram-negative bacterial receptor TLR4 and polyinosinic:polycytidylic acid (polyI:C) activates the viral receptor TLR3. TLR4 signaling involves TIRAP and TRIF, whereas TRIF is the only adaptor protein involved in the TLR3 pathway. We have shown previously that LPS-mediated downregulation of DMETs is independent of TIRAP. To determine the role of TRIF, we treated TRIF+/+ and TRIF−/− mice with LPS or polyI:C. LPS downregulated (∼40%–60%) Cyp3a11, Cyp2a4, Ugt1a1, Mrp2 mRNA levels, whereas polyI:C downregulated (∼30%–60%) Cyp3a11, Cyp2a4, Cyp1a2, Cyp2b10, Ugt1a1, Mrp2, and Mrp3 mRNA levels in TRIF+/+ mice. This downregulation was not attenuated in TRIF−/− mice. Induction of cytokines by LPS was observed in both TRIF+/+ and TRIF−/− mice. Cytokine induction was delayed in polyI:C-treated TRIF−/− mice, indicating that multiple mechanisms mediating polyI:C signaling exist. To assess the role of MAPKs, primary hepatocytes were pretreated with specific inhibitors before treatment with LPS/polyI:C. We found that only the c-jun-N-terminal kinase (JNK) inhibitor attenuated the down-regulation of DMETs. These results show that TRIF-independent pathways can be involved in the downregulation of DMETs through TLR4 and 3. JNK-dependent mechanisms likely mediate this downregulation.
机译:肝药物代谢酶和转运蛋白(DMET)的表达和活性在感染和炎症过程中发生改变。肝脏中的炎症反应主要由Toll样受体(TLR)信号介导,这涉及募集含有Toll /白介素(IL)-1受体(TIR)的含衔接子蛋白(TIRAP)和含TIR域的含衔接子的干扰素( IFN)-β(TRIF)最终导致促炎性细胞因子和促分裂原活化蛋白激酶(MAPK)的诱导。脂多糖(LPS)激活革兰氏阴性细菌受体TLR4,而多肌苷酸:聚胞苷酸(polyI:C)激活病毒受体TLR3。 TLR4信号传导涉及TIRAP和TRIF,而TRIF是唯一参与TLR3途径的衔接子蛋白。先前我们已经表明,LPS介导的DMETs下调独立于TIRAP。为了确定TRIF的作用,我们用LPS或polyI:C处理了TRIF + / + 和TRIF -/-小鼠。 LPS下调(〜40%–60%)Cyp3a11,Cyp2a4,Ugt1a1,Mrp2 mRNA水平,而polyI:C下调(〜30%–60%)Cyp3a11,Cyp2a4,Cyp1a2,Cyp2b10,Ugt1a1,Mrp2和Mrp3 mRNA水平TRIF + / + 小鼠。在TRIF -/-小鼠中这种下调没有减弱。在TRIF + / + 和TRIF -/-小鼠中均观察到LPS诱导的细胞因子。在polyI:C处理的TRIF -/-小鼠中,细胞因子的诱导被延迟,表明存在多种介导polyI:C信号传导的机制。为了评估MAPK的作用,在用LPS / polyI:C治疗之前,先用特异性抑制剂预处理原代肝细胞。我们发现只有c-jun-N-末端激酶(JNK)抑制剂可减弱DMET的下调。这些结果表明,不依赖TRIF的途径可通过TLR4和3参与DMET的下调。JNK依赖的机制可能介导此下调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号